Interleukin 21 News and Research

RSS
BMY and ZGen present Phase 1B results for PEG-Interferon lambda in HCV patients

BMY and ZGen present Phase 1B results for PEG-Interferon lambda in HCV patients

Phase 2 clinical study of PEG-Interferon lambda commenced

Phase 2 clinical study of PEG-Interferon lambda commenced

Phase 1b clinical trial results of PEG-Interferon lambda to be presented

Phase 1b clinical trial results of PEG-Interferon lambda to be presented

ZymoGenetics to provide company updates at upcoming investor conferences

ZymoGenetics to provide company updates at upcoming investor conferences

Chronic infection clearly linked to key immunity protein

Chronic infection clearly linked to key immunity protein

Blocked Interleukin 21 protein prevents Lupus in mouse model

Blocked Interleukin 21 protein prevents Lupus in mouse model

ZymoGenetics presents interim Interleukin 21 phase 2 results in renal cell cancer

ZymoGenetics presents interim Interleukin 21 phase 2 results in renal cell cancer

Novel ways to boost vaccination or natural defenses

Novel ways to boost vaccination or natural defenses

New genetic risk factor for coeliac disease

New genetic risk factor for coeliac disease

Interleukin 21 may enhance the effectiveness of Herceptin

Interleukin 21 may enhance the effectiveness of Herceptin

Bad hygiene may be good for you

Bad hygiene may be good for you